CVS Caremark Will Not Implement Planned 340B Payment Cuts
In a letter dated February 11, 2019, CVS Caremark announced that it will not implement its plan to reduce payment rates for pharmacies owned by 340B covered entities. These cuts…
CVS Caremark to Delay Reimbursement Cuts Until April 1
Earlier this week, CVS Caremark issued letters to 340B covered entity owned pharmacies announcing that it has delayed the scheduled cuts in reimbursement rates until April 1, 2019. In November…
California Medicaid Will Transition All Pharmacy Services to Fee-for-Service
On January 7, California Gov. Gavin Newsom signed an executive order instructing Medi-Cal to transition all pharmacy services for Medi-Cal managed care to fee-for-service (FFS) by January 2021. The directive…
Ryan White HIV/AIDS Providers Achieve Record Levels of Viral Suppression in 2017
In December, the Health Resources and Services Administration (HRSA) released a report affirming what RWCs know to be true – Ryan White HIV/AIDS providers are achieving record levels of viral…
Court Rules in Hospitals’ Favor in 340B OPPS Cuts Lawsuit
On December 27, 2018, the U.S. District Court for the District of Columbia struck down the portion of the 2018 OPPS rule that cut Medicare Part B drug reimbursement to…
2018 National Ryan White Conference
RWC-340B was proud to exhibit at the 2018 National Ryan White Conference on HIV Care & Treatment last week in Washington, DC. This was the first year that RWC-340B exhibited…
Proposed Rule Would Require Drug Manufacturers to Disclose Prices in TV Advertisements
On Monday, Health and Human Services Secretary Alex Azar announced a proposed rule that would require pharmaceutical manufacturers to disclose wholesale acquisition cost (“WAC”) prices in direct-to-consumer TV advertisements for…
Gilead Will Begin Marketing Lower Cost Hepatitis C Drugs in January
Gilead Sciences Inc. announced that it would begin selling generic versions of the company’s two leading treatments for hepatitis C at substantially reduced prices. The generic versions of Epclusa and…
Hospital Groups File Lawsuit Challenging CMP Rule Delay
Yesterday, four national hospital groups and three hospital systems filed a lawsuit against HHS over the continued delay of the implementation date of the 340B Ceiling Price and Manufacturer Civil…
Hospitals Refile Lawsuit Challenging 2018 OPPS Rule
Yesterday, hospital groups filed a second lawsuit challenging a nearly 30% reduction to Medicare Part B reimbursement for 340B drugs that went into effect January 1, 2018. The hospital originally…